Technical Analysis for APGE - Apogee Therapeutics, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Up | Flat |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Slingshot Bullish | Bullish Swing Setup | 0.00% | |
Upper Bollinger Band Walk | Strength | 0.00% | |
Multiple of Ten Bearish | Other | 0.00% | |
Upper Bollinger Band Walk | Strength | -5.14% | |
Multiple of Ten Bullish | Other | -5.14% | |
Gapped Up | Strength | -5.14% | |
Overbought Stochastic | Strength | -5.14% | |
Upper Bollinger Band Touch | Strength | -5.14% | |
Stochastic Sell Signal | Bearish | -6.17% | |
Upper Bollinger Band Walk | Strength | -6.17% |
Alert | Time |
---|---|
Fell Below 10 DMA | about 19 hours ago |
10 DMA Support | about 20 hours ago |
Down 5% | about 21 hours ago |
Down 1 ATR | about 21 hours ago |
Down 3% | about 23 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 08/12/2024
Apogee Therapeutics, Inc., through its subsidiary, operates as a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology indications. The company primarily develops APG777, a subcutaneous (SQ) extended half-life monoclonal antibody (mAb) for AD; and APG808, an SQ extended half-life mAb for COPD. Its earlier-stage programs include APG990, an SQ extended half-life mAb for the treatment of AD; and APG222, an extended half-life SQ antibodies for AD. The company was founded in 2022 and is based in Waltham, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Immunology Antibodies Monoclonal Antibodies Occupational Safety And Health Chronic Obstructive Pulmonary Disease Atopic Dermatitis Dermatitis Inflammatory Monoclonal Antibody Therapy Copd
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Immunology Antibodies Monoclonal Antibodies Occupational Safety And Health Chronic Obstructive Pulmonary Disease Atopic Dermatitis Dermatitis Inflammatory Monoclonal Antibody Therapy Copd
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 72.29 |
52 Week Low | 16.39 |
Average Volume | 410,161 |
200-Day Moving Average | 49.49 |
50-Day Moving Average | 54.61 |
20-Day Moving Average | 55.55 |
10-Day Moving Average | 57.18 |
Average True Range | 3.11 |
RSI (14) | 53.49 |
ADX | 17.68 |
+DI | 24.61 |
-DI | 19.78 |
Chandelier Exit (Long, 3 ATRs) | 54.18 |
Chandelier Exit (Short, 3 ATRs) | 59.80 |
Upper Bollinger Bands | 61.21 |
Lower Bollinger Band | 49.88 |
Percent B (%b) | 0.66 |
BandWidth | 20.39 |
MACD Line | 1.33 |
MACD Signal Line | 0.88 |
MACD Histogram | 0.4508 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 64.61 | ||||
Resistance 3 (R3) | 65.04 | 63.04 | 63.40 | ||
Resistance 2 (R2) | 63.04 | 61.19 | 62.83 | 63.00 | |
Resistance 1 (R1) | 60.20 | 60.05 | 59.20 | 59.77 | 62.59 |
Pivot Point | 58.20 | 58.20 | 57.71 | 57.99 | 58.20 |
Support 1 (S1) | 55.36 | 56.35 | 54.36 | 54.93 | 52.11 |
Support 2 (S2) | 53.36 | 55.21 | 53.15 | 51.70 | |
Support 3 (S3) | 50.52 | 53.36 | 51.30 | ||
Support 4 (S4) | 50.09 |